Technicals Stability Returns

TSR DIY Screener - A flexible way to create powerful strategy
  •   Powerful Strategy Builder
  •   Techno-Funda Filters in One
  •   Auto Refresh/Alerts
  •   TSR Live Plan @991/Yr
Fundamental Analysis of Medplus Health Services (MEDPLUS)

Summary    Balance Sheet    Cash Flow    Income    Qtrly Income    Valuation Ratio    Profitability Ratios    Solvency    Efficiency Ratios    

Guru Numbers
Book Value/Share126.49
EV/EBITDA39.78
Market Cap (Cr)7391.01
Enterprise Value (Cr)7369.55
Piotroski F-Score8.00
Altman Z Score6.07
Graham No111.73
Price/ Graham 5.54
Peter Lynch Ratio0.423
Sloan Ratio0.242
Peter Lynch Fair value109.65
Price/ Peter Lynch FV5.65
TSR Fair value342.29
Key Financial ratios of MEDPLUS
Ratio Latest FY Yoy Change TTM MRQ Screener/
About
Price to Earning    118.65 0 % 141.24    
Price to Book    8.02 0 % 7.16 5.18    
Price to Sales    3.20 0 % 1.95    
Earning Per Share    8.55 59.74 % 4.39 0.270    
Return On Equity    6.76 -22.70 % 5.07 0.226    
Return On Asset    3.69 -9.45 % 2.56 0.123    
Net Profit Margin    2.53 21.10 % 1.38 0.322    
Operating Profit Margin    4.05 -4.05 % 2.61 1.46    
EBITDA Margin    8.04 3.43 % 6.97 6.32    
Debt to Equity Ratio    0 0 % 0    
Current Ratio    2.92 31.21 % 2.92    
Quick Ratio    1.28 207.30 % 1.28    
View Historitcal ratios of Medplus Health Services Ltd.
Valuation Ratios   Profitability Ratio   Solvency Ratios   Efficiency Ratios
Screen Financial Ratio using Custom Screener
Terrific View
Tsr Stability Index - Excellent Score of 80.36
Piotroski F Score - Excellent Value of 8.0
Altman Z Score of 6.07 suggests good Stability
Company is Debt Free
Tremendous increasing in Book Value last 3 year
Company Earning excess return
Steady View
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Company financial liquidity has improved
Risky View
Tsr Value Index - Poor Score of 20.83
Tsr Profitability Index - Poor Score of 20.62
Price to Book Ratio of 4.90 suggesting that it is very expensive
Very Low Dividend Yield of 0 %
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Assets
EPS decline for last four quarters
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned40.10 %
Institution Owned32.30 %
Public/Others27.60 %
Outstanding Shares11.93 Cr
Floating Shares2.91 Cr
Floating / Outstanding24.42%
Book Value/Share126.49
Face value2.00
Share Holding
Annual Key Income Statement of MEDPLUS
Period 31_Mar_2022 31_Mar_2021 Growth
Net Income From Continuing Ops 94.72 63.11 50.09 %
Net Income 95.80 63.86 50.02 %
Operating Income 153.01 128.73 18.86 %
Total Revenue 3779.28 3050.78 23.88 %
Operating Expense 3626.27 2922.05 24.10 %
Interest Expense 66.43 53.62 23.89 %
Tax Expense 23.23 31.99 27.38 %
Income Before tax 117.94 95.10 24.02 %
Gross Profit 796.90 625.75 27.35 %
Dividend Paid 0 0 %
   
Quarterly Key Income Statement of MEDPLUS
Period 30_Jun_2022 31_Mar_2022 Growth
Net Income From Continuing Ops 3.68 11.43 67.80 %
Net Income 3.20 11.73 72.72 %
Operating Income 14.55 18.16 19.88 %
Total Revenue 993.65 965.91 2.87 %
Operating Expense 979.11 947.75 3.31 %
Interest Expense 19.81 18.58 6.62 %
Tax Expense 1.19 1.20 0.833 %
Income Before tax 4.87 12.63 61.44 %
Gross Profit 210.31 205.90 2.14 %
Dividend Paid 0 0 %
   
Key Balance Sheet Fields
Period 31_Mar_2022 31-Mar-21 Growth
Common Stock 23.86 0.448 5225.89 %
Current Liabilities 559.01 414.93 34.72 %
Total Liabilities 1176.78 834.55 41.01 %
Current Assets 1631.71 923.08 76.77 %
Total Assets 2594.05 1565.66 65.68 %
Working capital 1072.70 508.14 111.10 %
Accounts Payable 246.23 148.09 66.27 %
Inventory 914.98 749.96 22.00 %
Net Receivable 35.77 10.65 235.87 %
   
Key Cash Flow Fields
Period 31_Mar_2022 31_Mar_2021 Growth
Cash EPS 17.85 12.63 41.33 %
Cash From Investment Activity -703.13 -34.55 1935.11 %
Cash From Financial Activity 440.43 -5.63 7922.91 %
Cash Operational Activity 169.89 2.89 5778.55 %
Net Cash Flow -92.81 -37.28 148.95 %
NetIncome 95.80 63.86 50.02 %
Capital Expenditure 117.72 54.26 116.96 %
Change To Inventory -165.03 -106.40 55.10 %
   



   About Medplus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. As of March 31, 2021, it operated through 1,659 stores located in the states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, as well as through its online store. The company was incorporated in 2006 and is based in Hyderabad, India.

Address : Municipal No: 11-6-56, Hyderabad, India, 500072

URL : https://www.medplusindia.com

Employee Count : 18086

About TSR TECH Strength / Valuation / Growth

TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick

TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential

TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value

This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.